Atlas Trials

Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast Cancer

Clinical trial NCT00979641 · TERMINATED

Trial details

NCT number
NCT00979641
Sponsor
Tampere University Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Neoplasms
Start date
2009-01-01
Primary completion
2014-12-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.